Home NefroDiab


May 10th-11th 2019, Hotel Kronwell, Brasov

Scientific event organized by the Romanian Society of Diabetes, Nutrition and Metabolic Diseases in partnership with the Romanian Society of Nephrology.

Conference subjects:

• The role of SGLT2 inhibitors in renal and cardiovascular protection

• Protein malnutrition in patients with diabetic kidney disease

• The effect of intensive glycemic control on the risk of chronic kidney disease in patients with diabetes

• Renal effects of incretin medication

• Metformin in chronic kidney disease

• Management of type 2 diabetes in the elderly with fragility syndrome and / or chronic kidney disease

• What is the benefit of kidney transplantation in dialysis patients?

• Control of obesity in diabetic patients with kidney disease

• Can chronic kidney disease be prevented by lifestyle changes?

• Diet control and energy consumption in diabetic patients with kidney disease: the point of view of the diabetologist and nephrologist

• Aging, obesity, kidney and diabetes: molecular links and clinical implications

• What is the best way to treat polyneuropathy in patients with diabetes and kidney failure?

• Should patients with chronic stage 5 kidney disease and diabetes start with peritoneal dialysis or hemodialysis?

• Oral medications: is one superior to another in terms of mortality / complications / glycemic control in diabetic patients with renal impairment or dialysis?

• Improving the management of type 1 diabetes: glycemic sensors, insulin pumps or both?

• Should antiplatelet therapy be recommended in diabetic patients with renal impairment regardless of cardiovascular risk?

More details on www.nefrodiab.ro